Synairgen PLC (LSE:SNG) - Share price - Overview

Stock Report

Synairgen PLC SNG

Last Price
GBX18.00

Day Change
-0.50|-2.70%

As of 18/07/2018
16:18:34 BST | GBX
Minimum 15 Minutes Delay.

Last Close18.50p
Day Range17.20 - 18.20
Mkt Cap16.46Mil
52-Wk Range6.98 - 27.00
Yield %-
ISINGB00B0381Z20
Volume114,053
P/E9.63
P/S0.03
P/CF0.08

Share Price

Total Returns 18/07/2018

 Chg (%)  
More ...
Synairgen PLC33.33 
FTSE 100 TR GBP0.72
 
Financials
201520162017
More ...
Income Statement
Turnover0.030.005.03
Operating Profit-2.61-3.441.62
Net Profit-2.26-2.821.76
Reported EPS-2.47-3.081.87
Balance Sheet
Current Assets8.195.477.61
Non Current Assets0.100.080.06
Total Assets8.285.557.66
Current Liabilities0.940.861.10
Total Liabilities0.940.861.10
Total Equity7.354.696.56
Cash Flow
Operating Cash Flow-1.99-3.321.45
Net Change in Cash1.15-0.891.74

Company Profile

Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.

Sector

Biotechnology

Index

FTSE AIM All-Share

Next Event 27/09/2018

Half-Yearly Results
Ratios
Comp
More ...
PER (E)9.89
Div Yld (E)0.00
PEG (E)0.00
ROCE24.62
Op Mrgn0.32
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. Iain Peter Murray Buchanan
Non-Executive Director, ChairmanMr. Simon James Blouet Shaw
Non-Executive DirectorDr David Bruce Campbell
Executive Director, Chief Executive OfficerMr Richard James Marsden
Non-Executive DirectorProf Stephen Townley Holgate CBE
Executive Director, Chief Scientific OfficerDr Phillip David Monk
Non-Executive DirectorMr. Paul Hugh Anthony Clegg
Executive Director, Finance Director and Company SecretaryJohn Christopher Ward
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.